---
figid: PMC6747549__ijms-20-04146-g001
figlink: /pmc/articles/PMC6747549/figure/ijms-20-04146-f001/
number: F1
caption: 'Schematic summary of the molecular pathways of F. nucleatum in CRC tumorigenesis.
  F. nucleatum mediates its oncogenic properties through three major components: the
  Fap2, and FadA molecules along with the LPS. LPS can interact with TLRs (namely
  TLR2 or TLR4), activating the MyD88 and NF-κΒ pathway. This interaction leads to
  reduced caspase activity and increased autophagy, resulting in reduced apoptosis.
  Furthermore, FadA binds to E-cadherin, causing dephosphorylation and activation
  of β-catenin. NF-κΒ and β-catenin alter the gene expression, increasing the synthesis
  of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-18, TNF-α) and upregulating
  oncogenic pathways of Cmyc/CyclinD and miR-21. The pro-inflammatory state is further
  enhanced by the binding of Fap2 to Gal-GalNAc. Additionally, the interaction of
  LPS with the TIGIT receptor of NK and T cells leads to suppression of anti-tumor
  immunity. Eventually, these events create inflammation which impairs DNA, promotes
  cell proliferation and results in CRC tumorigenesis. CRC: colorectal cancer; Gal-GalNAc:
  D-galactose-β(1–3)-N-acetyl-D-galactosamine; IL: interleukin, LPS: lipopolysaccharide;
  miR: microRNA: NF-κΒ: nuclear factor kappa-beta; NK: natural-killer; TIGIT: T-cell
  immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain; TLR: toll-like
  receptor; TNF-α: tumor necrosis factor-alpha. Upward red arrows: enhancement/stimulation;
  Downward red arrows: reduction.'
pmcid: PMC6747549
papertitle: Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer.
reftext: Ioannis Koliarakis, et al. Int J Mol Sci. 2019 Sep;20(17):4146.
pmc_ranked_result_index: '68817'
pathway_score: 0.9620243
filename: ijms-20-04146-g001.jpg
figtitle: Schematic summary of the molecular pathways of F
year: '2019'
organisms:
- Homo sapiens
ndex: 33d2ec14-ded6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6747549__ijms-20-04146-g001.html
  '@type': Dataset
  description: 'Schematic summary of the molecular pathways of F. nucleatum in CRC
    tumorigenesis. F. nucleatum mediates its oncogenic properties through three major
    components: the Fap2, and FadA molecules along with the LPS. LPS can interact
    with TLRs (namely TLR2 or TLR4), activating the MyD88 and NF-κΒ pathway. This
    interaction leads to reduced caspase activity and increased autophagy, resulting
    in reduced apoptosis. Furthermore, FadA binds to E-cadherin, causing dephosphorylation
    and activation of β-catenin. NF-κΒ and β-catenin alter the gene expression, increasing
    the synthesis of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, IL-18, TNF-α)
    and upregulating oncogenic pathways of Cmyc/CyclinD and miR-21. The pro-inflammatory
    state is further enhanced by the binding of Fap2 to Gal-GalNAc. Additionally,
    the interaction of LPS with the TIGIT receptor of NK and T cells leads to suppression
    of anti-tumor immunity. Eventually, these events create inflammation which impairs
    DNA, promotes cell proliferation and results in CRC tumorigenesis. CRC: colorectal
    cancer; Gal-GalNAc: D-galactose-β(1–3)-N-acetyl-D-galactosamine; IL: interleukin,
    LPS: lipopolysaccharide; miR: microRNA: NF-κΒ: nuclear factor kappa-beta; NK:
    natural-killer; TIGIT: T-cell immunoglobulin and immunoreceptor tyrosine-based
    inhibitory motif domain; TLR: toll-like receptor; TNF-α: tumor necrosis factor-alpha.
    Upward red arrows: enhancement/stimulation; Downward red arrows: reduction.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CASP8
  - CASP9
  - CASP7
  - MYC
  - CCND1
  - CASP10
  - CDH1
  - IL1B
  - IL6
  - CCND2
  - CASP6
  - IRF6
  - MYD88
  - NFKB1
  - TIGIT
  - CCND3
  - CTNNB1
  - CASP12
  - CASP14
  - CASP1
  - CASP2
  - CASP3
  - IL18
  - CXCL8
  - CASP5
  - TNF
  - CASP4
  - LPS
genes:
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Cmyc/CyclinD
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Cmyc/CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: IL-1B,IL-6,
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-1B,IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: Cmyc/CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND2
  entrez: '894'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: MyD88
  symbol: MYD88
  source: hgnc_symbol
  hgnc_symbol: MYD88
  entrez: '4615'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: TIGIT
  symbol: TIGIT
  source: hgnc_symbol
  hgnc_symbol: TIGIT
  entrez: '201633'
- word: Cmyc/CyclinD
  symbol: Cyclin_D
  source: bioentities_symbol
  hgnc_symbol: CCND3
  entrez: '896'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: IL-8,IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-8,IL-18,
  symbol: IL-8
  source: hgnc_alias_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: TNF-a
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
chemicals: []
diseases:
- word: LPS
  source: MESH
  identifier: C536528
figid_alias: PMC6747549__F1
redirect_from: /figures/PMC6747549__F1
figtype: Figure
---
